PS Ratio: 2472.93

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 2472.93 is 1767% above its estimated 4-year average of 132.42, around the middle of its estimated 4-year range (7.42–4049.71).

As of 2026-10-06T16:56:31.544Z. 36.91% above its estimated 12-month average of 1806.21.

DNTH PS Ratio Metrics

P/S vs. estimated history

At 2472.93, P/S is at an extreme level, where the multiple carries little signal — higher than 89% of readings in its estimated 4-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Dianthus Therapeutics, Inc. (DNTH)?

The P/S ratio for DNTH stock is 2472.93.

Is Dianthus Therapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 2472.93 is 1767% above its estimated 4-year average of 132.42, around the middle of its estimated 4-year range (7.42–4049.71).

What is the estimated TTM average P/S ratio for Dianthus Therapeutics, Inc. (DNTH)?

The estimated TTM average P/S ratio for DNTH stock is 1806.21.

What is the estimated 3Y average P/S ratio for Dianthus Therapeutics, Inc. (DNTH)?

The estimated 3Y average P/S ratio for DNTH stock is 190.69.

Showing the most recent 260 of 981 data points. The chart above shows the full history.

Related Metrics